Illumine Financial Partners, associates with MassMutual of South Carolina for a Balanced Offering and Financial Planning Capabilities
MassMutual of SC Welcomes Illumine Financial Partners, led by David Horine, ChFC®, ChSNC® and Andrew Schmidt. CHARLESTON, S.C., Aug. 8, 2025 /PRNewswire/ — Financial planning practice, Illumine Financial Partners has joined MassMutual of South Carolina. Their practice, located in Charleston S.C. is led by David Horine, ChFC®, ChSNC® who specializes in helping educate business owners, […]
RBL LLC secures investment from Modi Ventures
– Strategic investment to support RBL’s mission to launch and scale breakthrough startups – Founder and general partner of Modi Ventures, Sahir Ali, to join RBL board of directors – Modi Ventures’ Ali, RBL managing partner Wotton to speak on venture creation at Canaccord Genuity Growth Conference Aug. 12 HOUSTON, Aug. 8, 2025 /PRNewswire/ — […]
BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update
Call Scheduled for August 14, 2025, at 8:30 AM Eastern Time NEW YORK, Aug. 8, 2025 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a conference call and webcast to update shareholders on financial results for the second quarter of […]
Calumet Reports Second Quarter 2025 Results
Second quarter 2025 net loss of $147.9 million, or basic loss per common share of $1.70 per share Second quarter 2025 Adjusted EBITDA with Tax Attributes of $76.5 million Company-wide cost reduction initiatives tracking ahead of plan, delivering $42 million in year-over-year operating cost savings through the first half of 2025 Montana Renewables remains on […]
HOTELEX Shanghai 2026 se prepara para batir récords con una escala sin precedentes y alcance global
SHANGHÁI, 8 de agosto de 2025 /PRNewswire/ — HOTELEX Shanghai, la principal feria de hostelería y restauración de Asia, se celebrará del 30 de marzo al 2 de abril de 2026 en el Centro Nacional de Exposiciones y Convenciones (NECC). Con una superficie ampliada de 400.000 metros cuadrados, el evento acogerá a más de 3.500 […]
THE WENDY’S COMPANY REPORTS SECOND QUARTER 2025 RESULTS
Global systemwide sales were $3.7 billion, a decrease of 1.8% International systemwide sales grew 8.7% with growth across all regions Added 26 net new restaurants and remain on track to deliver full-year net unit growth between 2-3% Reported diluted earnings per share and adjusted earnings per share were $0.29, an increase of 7.4% Returned $88.7 […]
HK-listed IVD Medical Invests HK$149M in Ethereum through HashKey Exchange
HONG KONG, Aug. 8, 2025 /PRNewswire/ — HashKey Exchange, Hong Kong’s largest * licensed virtual asset trading platform, has entered into a strategic partnership with IVD Medical Holdings Limited, a publicly listed company on the Hong Kong Stock Exchange. The two parties will collaborate to advance enterprise-level digital asset adoption and explore new models for […]
Tredence powołuje Shriharshę Imprapura na stanowisko Chief Business Officer na region Wielkiej Brytanii i Europy
LONDYN, 8 sierpnia 2025 r. /PRNewswire/ — Firma Tredence, lider rynku rozwiązań w dziedzinie nauk o danych i SI, powołała Shriharshę Imprapura na stanowisko Chief Business Officer w Wielkiej Brytanii i Europie. Continue Reading Shriharsha Imrapur, Chief Business Officer for UK & Europe, Tredence Biuro Harshy znajdować będzie się będzie w Londynie, a do jego zadań […]
RemeGen’s Independently-Developed Bispecific Antibody RC148 Approved to Proceed Phase II Clinical Trial in US by FDA
YANTAI, China, Aug. 8, 2025 /PRNewswire/ — On August 8th, RemeGen Co., Ltd. (688331.SH/09995.HK) announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bispecific antibody, RC148, for the treatment of multiple advanced malignant solid tumors in the US. RC148 is a PD-1 and VEGF-targeting bispecific […]
WuXi XDC Included in MSCI China All Share Index
SHANGHAI, Aug. 8, 2025 /PRNewswire/ — WuXi XDC Cayman Inc. (“WuXi XDC”, stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today announced its inclusion in the MSCI China All Share Index, which underscores global capital markets’ recognition of the company’s sustained growth value and leadership […]